Immunocore Holdings PLC (IMCR)
32.28
+0.16
(+0.50%)
USD |
NASDAQ |
Nov 22, 16:00
32.22
-0.06
(-0.19%)
After-Hours: 20:00
Immunocore Holdings Profit Margin (Quarterly): 10.89% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.89% |
| June 30, 2024 | -15.41% |
| March 31, 2024 | -34.66% |
| December 31, 2023 | -28.12% |
| September 30, 2023 | 1.40% |
| June 30, 2023 | -28.47% |
| March 31, 2023 | -35.58% |
| December 31, 2022 | -51.32% |
| September 30, 2022 | 15.12% |
| June 30, 2022 | -19.13% |
| Date | Value |
|---|---|
| March 31, 2022 | -71.76% |
| December 31, 2021 | -579.0% |
| September 30, 2021 | -508.7% |
| June 30, 2021 | -575.0% |
| March 31, 2021 | -351.1% |
| December 31, 2020 | -252.8% |
| September 30, 2020 | -291.0% |
| June 30, 2020 | -221.1% |
| March 31, 2020 | -225.8% |
| December 31, 2019 | -447.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-579.0%
Minimum
Dec 2021
15.12%
Maximum
Sep 2022
-185.4%
Average
-61.54%
Median
Profit Margin (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -43.07% |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | -763.9% |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -12.92% |
| Return on Assets | -5.52% |
| Return on Invested Capital | -7.28% |
| Gross Profit Margin (Quarterly) | 99.44% |
| Operating Margin (Quarterly) | -10.59% |
| Return on Net Operating Assets | -42.81% |